All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 242 points (1.5%) at 16,127 as of Tuesday, Jan. 26, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,449 issues advancing vs. 538 declining with 103 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 1.0%. Top gainers within the industry include

Community Health Systems

(

CYH

), up 5.5%,

DENTSPLY International

(

XRAY

), up 2.0%,

Abbott Laboratories

(

ABT

), up 1.2%,

Fresenius Medical Care AG & Co. KGaA

(

FMS

), up 0.6% and

Stryker Corporation

(

SYK

), up 0.5%. On the negative front, top decliners within the industry include

Waters

(

WAT

), down 4.1%,

Aetna

(

AET

), down 1.1% and

CR Bard

(

BCR

), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Zimmer Biomet Holdings

(

ZBH

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Zimmer Biomet Holdings is up $1.81 (1.8%) to $100.87 on light volume. Thus far, 445,898 shares of Zimmer Biomet Holdings exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $99.37-$101.11 after having opened the day at $99.58 as compared to the previous trading day's close of $99.06.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Biomet Holdings has a market cap of $20.2 billion and is part of the health care sector. Shares are down 3.4% year-to-date as of the close of trading on Monday. Currently there are 15 analysts who rate Zimmer Biomet Holdings a buy, no analysts rate it a sell, and 6 rate it a hold.

TST Recommends

TheStreet Ratings rates

Zimmer Biomet Holdings

as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full

Zimmer Biomet Holdings Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Baxter International

(

BAX

) is up $0.34 (1.0%) to $36.40 on light volume. Thus far, 746,625 shares of Baxter International exchanged hands as compared to its average daily volume of 4.6 million shares. The stock has ranged in price between $35.98-$36.56 after having opened the day at $36.14 as compared to the previous trading day's close of $36.05.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $19.7 billion and is part of the health care sector. Shares are down 5.5% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Baxter International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

HCA Holdings

(

HCA

) is up $1.05 (1.6%) to $66.63 on light volume. Thus far, 1.0 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 4.2 million shares. The stock has ranged in price between $65.39-$66.78 after having opened the day at $65.72 as compared to the previous trading day's close of $65.58.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $26.8 billion and is part of the health care sector. Shares are down 3.0% year-to-date as of the close of trading on Monday. Currently there are 14 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates

HCA Holdings

as a

hold

. Among the primary strengths of the company is its revenue growth. At the same time, however, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and poor profit margins. Get the full

HCA Holdings Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).